Aspergillosis: Emerging risk groups in critically ill patients.
Stefan KlugeRichard StraußMatthias KochanekMarkus A WeigandHolger RohdeTobias LahmerPublished in: Medical mycology (2021)
The use of corticosteroids and the presence of co-morbidities such as chronic obstructive pulmonary disease, acute or chronic advanced liver disease, or severe viral pneumonia caused by influenza or Covid-19, may increase the risk of invasive aspergillosis in intensive care unit patients.
Keyphrases
- intensive care unit
- chronic obstructive pulmonary disease
- sars cov
- end stage renal disease
- coronavirus disease
- ejection fraction
- chronic kidney disease
- newly diagnosed
- respiratory failure
- drug induced
- liver failure
- peritoneal dialysis
- early onset
- mechanical ventilation
- patient reported
- hepatitis b virus
- acute respiratory distress syndrome